The small-cap biotech stock highlighted in today’s article has “slipped under the radar due to the coronavirus pandemic”, the author notes. But with two major catalysts coming up this year, could this obscure stock be poised to make early investors a fortune? For a deeper look at this stock, its upcoming catalysts, and the author’s recommended action, CLICK HERE.